Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
International Aids Vaccine Initiative Inc. has 1 pending office action in Biotechnology & Pharmaceuticals. The matter is assigned to 1 distinct examiner and 1 distinct art unit, concentrating the identified prosecution activity within one examination channel. This supports a focused review of the application record and the technical basis for response.
GANGLE, BRIAN J is the busiest examiner, with 1 pending matter. The matching figures indicate that this examiner handles the identified pending action. Counsel can therefore direct claim analysis, amendments, and supporting explanations to the specific biotechnology or pharmaceutical issues in the assigned application.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GANGLE, BRIAN J | 1 | 76.8% | +14.6% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18461754 | Tuberculosis Compositions And Methods Of Using The Same | GANGLE, BRIAN J | — |
| Art Unit | Apps |
|---|---|
| 1645 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18461754 | Tuberculosis Compositions And Methods Of Using The Same | GANGLE, BRIAN J | 1645 | §112Other | Final Rejection | — | Pending | Sep 06, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialInternational Aids Vaccine Initiative Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Brian J Gangle has the most, with 1 of International Aids Vaccine Initiative Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
